Olgram develops new drugs to cure immune deficiencies for which there are no satisfactory therapeutic solutions. Our 1st clinical application is immunodepression post traumatic brain injury, affecting 5 million people. We also develop new anti-infectious to cure the chronic bacterial infection.
- https://www.olgram.com
- +41 78 217 74 05
- pierre.rocheteau@olgram.com
- Pierre Rocheteau
Some insights
The passion, determination and expertise of Olgram’s management and founders have led to many important developments in the field of medicine, driven by innovation and the improvement of the quality of life of patients around the world with extensive experiences in human and animal therapeutics.